Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 268

1.

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).

Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G.

Vasc Health Risk Manag. 2008;4(1):31-8. Review.

PMID:
18629361
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher).

Biondi-Zoccai G, Lotrionte M, Moretti C, Agostoni P, Sillano D, Laudito A, Sheiban I.

Minerva Cardioangiol. 2008 Feb;56(1):55-65. Review.

PMID:
18432169
[PubMed - indexed for MEDLINE]
3.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
[PubMed - indexed for MEDLINE]
4.

Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.

Waksman R, Barbash IM, Dvir D, Torguson R, Ben-Dor I, Maluenda G, Xue Z, Satler LF, Suddath WO, Kent KM, Pichard AD.

Am J Cardiol. 2012 May 1;109(9):1288-94. doi: 10.1016/j.amjcard.2011.12.019. Epub 2012 Feb 15.

PMID:
22341925
[PubMed - indexed for MEDLINE]
5.

XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.

Beijk MA, Piek JJ.

Expert Rev Med Devices. 2007 Jan;4(1):11-21. Review.

PMID:
17187467
[PubMed - indexed for MEDLINE]
6.

Current status of the Xience V® everolimus-eluting coronary stent system.

Claessen BE, Caixeta A, Henriques JP, Piek JJ.

Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1363-74. doi: 10.1586/erc.10.127. Review.

PMID:
20936921
[PubMed - indexed for MEDLINE]
7.

Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.

Byrne RA, Sarafoff N, Kastrati A, Schömig A.

Drug Saf. 2009;32(9):749-70. doi: 10.2165/11316500-000000000-00000. Review.

PMID:
19670915
[PubMed - indexed for MEDLINE]
8.
9.

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.

Kirchner RM, Abbott JD.

Vasc Health Risk Manag. 2009;5:1089-97. Epub 2009 Dec 29. Review.

PMID:
20057901
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.

Hofma SH, Brouwer J, Velders MA, van't Hof AW, Smits PC, Queré M, de Vries CJ, van Boven AJ.

J Am Coll Cardiol. 2012 Jul 31;60(5):381-7. doi: 10.1016/j.jacc.2012.01.073.

PMID:
22835668
[PubMed - indexed for MEDLINE]
Free Article
11.

Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.

Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W.

EuroIntervention. 2011 May;7 Suppl K:K100-5. doi: 10.4244/EIJV7SKA17.

PMID:
22027717
[PubMed - indexed for MEDLINE]
12.

Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.

Lansky AJ, Ng VG, Mutlu H, Cristea E, Guiran JB, Midei M, Newman W, Sanz M, Sood P, Doostzadeh J, Su X, White R, Cao S, Sudhir K, Stone GW.

Catheter Cardiovasc Interv. 2009 Nov 1;74(5):719-27. doi: 10.1002/ccd.22067.

PMID:
19530147
[PubMed - indexed for MEDLINE]
14.

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.

Wiemer M, Serruys PW, Miquel-Hebert K, Neumann FJ, Piek JJ, Grube E, Haase J, Thuesen L, Hamm C.

Catheter Cardiovasc Interv. 2010 Jun 1;75(7):997-1003. doi: 10.1002/ccd.22428.

PMID:
20517959
[PubMed - indexed for MEDLINE]
15.

Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease.

Jensen LO, Thayssen P, Tilsted HH, Ravkilde J, Junker A, Hansen HS, Hansen KN, Pedersen KE, Sørensen HT, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome SORT OUT IV investigators.

Cardiology. 2010;116(2):73-8. doi: 10.1159/000315136. Epub 2010 Jun 3.

PMID:
20523042
[PubMed - indexed for MEDLINE]
16.

Xience V everolimus-eluting coronary stent.

Kukreja N, Onuma Y, Serruys PW.

Expert Rev Med Devices. 2009 May;6(3):219-29. doi: 10.1586/erd.09.1. Review.

PMID:
19419279
[PubMed - indexed for MEDLINE]
17.

Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.

Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS.

J Am Coll Cardiol. 2011 Oct 25;58(18):1844-54. doi: 10.1016/j.jacc.2011.07.031.

PMID:
22018294
[PubMed - indexed for MEDLINE]
Free Article
18.

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.

Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators.

Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.

PMID:
19171853
[PubMed - indexed for MEDLINE]
Free Article
19.

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.

Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, Faxon DP, Feit F.

BMJ. 2013 Nov 8;347:f6625. doi: 10.1136/bmj.f6625.

PMID:
24212107
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[When are drug-eluting stents effective? A critical analysis of the presently available data].

Silber S.

Z Kardiol. 2004 Sep;93(9):649-63. Review. German.

PMID:
15365732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk